Corbus Pharmaceuticals Holdings Inc. Stock Climbs 5.4%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rallied 5.4% to $9.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.2% to 25,137.69 and Dow Jones Industrial Average falling 1.0% to 51,711.65.

Corbus Pharmaceuticals Holdings Inc. closed 54.7% below its 52-week high of $20.56, which the company reached on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 0.2% to $5.36, Fortress Biotech Inc. fell 3.4% to $3.43, and Viking Therapeutics Inc. fell 5.15% to $35.39.

Trading volume totaled 638,462, compared to the 50-day average of 530,252.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 23, 2026 16:35 ET (20:35 GMT)